These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17917387)

  • 21. Application of polymerase chain reaction to analysis of antigen receptor rearrangements to support endoscopic diagnosis of canine alimentary lymphoma.
    Kaneko N; Yamamoto Y; Wada Y; Shimokawa Miyama T; Hiraoka H; Itamoto K; Mizuno T; Nakaichi M; Takahashi T; Watari T; Okuda M
    J Vet Med Sci; 2009 May; 71(5):555-9. PubMed ID: 19498279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal lymphoma in 20 dogs. A retrospective study.
    Couto CG; Rutgers HC; Sherding RG; Rojko J
    J Vet Intern Med; 1989; 3(2):73-8. PubMed ID: 2715959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Canine intravascular lymphoma with overt leukemia.
    Lane LV; Allison RW; Rizzi TR; Stern AW; Snider TA; Moore PF; Vernau W
    Vet Clin Pathol; 2012 Mar; 41(1):84-91. PubMed ID: 22260096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heteroduplex polymerase chain reaction is essential for canine receptor rearrangement analysis.
    Takanosu M; Tadika T; Kobayashi T
    J Vet Diagn Invest; 2010 Sep; 22(5):760-3. PubMed ID: 20807937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epirubicin as part of a multi-agent chemotherapy protocol for canine lymphoma.
    Elliott JW; Cripps P; Marrington AM; Grant IA; Blackwood L
    Vet Comp Oncol; 2013 Sep; 11(3):185-98. PubMed ID: 22372620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of relapsed canine lymphoma with doxorubicin and dacarbazine.
    Van Vechten M; Helfand SC; Jeglum KA
    J Vet Intern Med; 1990; 4(4):187-91. PubMed ID: 2401965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a 15-week CHOP protocol for the treatment of canine multicentric lymphoma.
    Burton JH; Garrett-Mayer E; Thamm DH
    Vet Comp Oncol; 2013 Dec; 11(4):306-15. PubMed ID: 22548975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The bone biologic effects of zoledronate in healthy dogs and dogs with malignant osteolysis.
    Fan TM; de Lorimier LP; Garrett LD; Lacoste HI
    J Vet Intern Med; 2008; 22(2):380-7. PubMed ID: 18346146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of Lymphoid Molecular Clonality in Canine Thymoma.
    Vessieres F; Rasotto R; Peters I; Villiers E; Berlato D; Cian F
    J Comp Pathol; 2018 Jan; 158():66-70. PubMed ID: 29422318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical multiple myeloma in 3 young dogs.
    Wachowiak IJ; Moore AR; Avery A; Magunda F; Harris A; Laurence H; Fulkerson CM; Fulkerson CV; Messick JB; Strandberg NJ; McGrath S
    Vet Pathol; 2022 Sep; 59(5):787-791. PubMed ID: 35400242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity for the detection of a clonally rearranged antigen receptor gene in endoscopically obtained biopsy specimens from canine alimentary lymphoma.
    Fukushima K; Ohno K; Koshino-Goto Y; Uchida K; Nomura K; Takahashi M; Nakashima K; Fujino Y; Tsujimoto H
    J Vet Med Sci; 2009 Dec; 71(12):1673-6. PubMed ID: 20046040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is your diagnosis? Ocular lymphoma.
    Cave T; Billson M
    J Small Anim Pract; 2003 Dec; 44(12):523, 553-4. PubMed ID: 14692547
    [No Abstract]   [Full Text] [Related]  

  • 33. Stage migration in dogs with lymphoma.
    Flory AB; Rassnick KM; Stokol T; Scrivani PV; Erb HN
    J Vet Intern Med; 2007; 21(5):1041-7. PubMed ID: 17939562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring minimal residual disease in canine lymphomas treated with modified L-COP or L-CHOP protocols.
    Sirivisoot S; Teewasutrakul P; Techangamsuwan S; Tangkawattana S; Rungsipipat A
    Acta Vet Hung; 2018 Mar; 66(1):66-84. PubMed ID: 29580085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thirteen-week dose-intensifying simultaneous combination chemotherapy protocol for malignant lymphoma in dogs.
    Zenker I; Meichner K; Steinle K; Kessler M; Hirschberger J
    Vet Rec; 2010 Nov; 167(19):744-8. PubMed ID: 21257510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma.
    Rütgen BC; Hammer SE; Gerner W; Christian M; de Arespacochaga AG; Willmann M; Kleiter M; Schwendenwein I; Saalmüller A
    Leuk Res; 2010 Jul; 34(7):932-8. PubMed ID: 20153049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A combination chemotherapy protocol with dose intensification and autologous bone marrow transplant (VELCAP-HDC) for canine lymphoma.
    Frimberger AE; Moore AS; Rassnick KM; Cotter SM; O'Sullivan JL; Quesenberry PJ
    J Vet Intern Med; 2006; 20(2):355-64. PubMed ID: 16594594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute promyelocytic leukaemia complicating multiple myeloma: evidence of different cell lineages.
    Dunkley S; Gibson J; Iland H; Li C; Joshua D
    Leuk Lymphoma; 1999 Nov; 35(5-6):623-6. PubMed ID: 10609802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of canine lymphoma with COPLA/LVP.
    Boyce KL; Kitchell BE
    J Am Anim Hosp Assoc; 2000; 36(5):395-403. PubMed ID: 10997514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous marrow transplantation as consolidation therapy for canine lymphoma: efficacy and toxicity of various regimens of total body irradiation.
    Deeg HJ; Appelbaum FR; Weiden PL; Hackman RC; Graham TC; Storb RC
    Am J Vet Res; 1985 Sep; 46(9):2016-8. PubMed ID: 3901841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.